CN1226439A - Composite medicinal injection for hemiparalysis - Google Patents
Composite medicinal injection for hemiparalysis Download PDFInfo
- Publication number
- CN1226439A CN1226439A CN 98122910 CN98122910A CN1226439A CN 1226439 A CN1226439 A CN 1226439A CN 98122910 CN98122910 CN 98122910 CN 98122910 A CN98122910 A CN 98122910A CN 1226439 A CN1226439 A CN 1226439A
- Authority
- CN
- China
- Prior art keywords
- injection
- cobastab
- treatment
- hydrochloride
- ligustrazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A composite injection for treating hemiplegia, poliomyelitic sequela and myasthenia gravis with effective rate of 95-100% contains such components as VB1, VB6, VB12, red sage root injection, ligustrazine phosphate or hydrochloride, corenalin, physiological saline, etc. It serves to improve the functions of damaged nerve and vascular system, restore the movement function of limbs and atrophic muscle tissue and increase memory power.
Description
The present invention relates to a kind of composite medicinal injection, particularly a kind of composite medicinal injection for the treatment of hemiplegia.
Annual nearly 263 people of China suffer from cerebral apoplexy. In the middle of 1,240,000 people from left and right sides of survival, 80% deformity that leaves is in various degree arranged approximately, need to treat (Wang Hongzhong, Xu Jianpeng chief editor " practical combination of Chinese tradiational and Western medicine hemiparalysis recovery is learned ", Chinese Medicine science and technology publishing house, in May, 1997, front page). At present medical circle has been carried out a large amount of research to the cause of disease, morbidity, diagnosis and the treatment of apoplexy, and makes great progress, but less to the research of paralytic's rehabilitation. According to clinical medical custom, as long as function stop such as hemiparalysis human motions, therapeutic process also just finishes. Be used for the treatment of at present hemiplegia mainly with kinesiatrics, acupuncture therapy, treatment by Chinese herbs (what wide new volume " stroke rehabilitation and acupuncture-moxibustion " that waits, China Traditional Chinese Medicine Publishing House, in November, 1997 front page). But existing methods for the treatment of all exists the course for the treatment of long, efficient low problem, and the patient is difficult to reach self care ability.
The purpose of this invention is to provide a kind of composite medicinal injection that can effectively treat hemiplegia.
Technical scheme of the present invention is as follows: Cobastab, the red sage root, ligustrazine, a leaf autumn alkali, citicoline are mixed with a kind of muscle or acupoint injection therapy liquid by a certain percentage. Its composition of medicine component content (by working concentration mg/100ml) is:
Cobastab1 400-800mg
Cobastab6 50-100mg
Cobastab12 5-10mg
Danshen injections (crude drug content) 3000-6000mg
Ligustrazine phosphat or Securinine hydrochloride 380-750mg
One leaf autumn of nitric acid alkali or Securinine hydrochloride 8-16mg
CDPC 500-1000mg
All the other are assigned to 100ml with 0.9% physiological saline.
Danshen injections in the such scheme can be with pure danshen injections, compound injection of red sage root or sodium tashinone II A sulfonate injection.
Composite medicinal injection of the present invention, owing to contain central nervous system in the prescription, particularly spinal cord has a leaf autumn alkali of appreciable stimulating action; CDPC in the prescription can promote lecithin synthetic, and excited reticular formation of brain stem recovers the nerve fiber function and improves the brain metabolism; The red sage root in the prescription, ligustrazine can improve brain microcirculation and brain blood flow, improve the ability of organizing anti-anoxic; And Cobastab same clan medicine can participate in various metabolic processes in the body, and is particularly evident to nerve and vascular system. The combination of above medicine can improve the function of injured nerve, vascular system, can recover quickly and effectively the autokinetic movement function of paralyzed limbs, atrophied musculature is restored in a short period of time, and can improves patient's memory and improve to greatest extent handicapped person's functional status and raising self care ability.
Adopt composite medicinal injection of the present invention, except being used for the treatment of hemiplegia, can also be used for the treatment of sequelae of infantile paralysis, myasthenia gravis, progressive muscular dystrophy. Use and efficiently in efficient 95%, three ten day in this parenteral solution ten days reach 100%.
Below in conjunction with embodiment and the treatment case the present invention is further illustrated.
The embodiment I
The preparation of this composite medicinal injection (pressing mg/100ml), with commercially available finished product parenteral solution, prescription:
Cobastab1 800mg
Cobastab6 100mg
Cobastab12 10mg
Compound Danshen Root (or sodium tanshinon Ⅱa silate) 3000mg
Ligustrazine phosphat (or Ligustrazine Hydrochloride) 750mg
Nitric acid one leaf autumn alkali (or Securinine hydrochloride) 16mg
Citicoline 10O0mg
All the other join 100ml with 0.9% physiological saline.
Be used for that elbow appears bending in hemiplegia, upper limbs, the wrist that hangs down, count on one's fingers etc., select 5 acupoint injection therapies at every turn, every cave 1ml, once a day. Be used for lower limb and drop foot, strephenopodia etc. occur, select 5 acupoint injection therapies at every turn, every cave 1ml, once a day.
The embodiment II
The preparation of this composite medicinal injection (pressing mg/100ml), with commercially available finished product parenteral solution, prescription:
Cobastab1 600mg
Cobastab6 80mg
Cobastab12 8mg
Compound Danshen Root (or sodium tanshinon Ⅱa silate) 5000mg
Ligustrazine phosphat (or Ligustrazine Hydrochloride) 600mg
Nitric acid one leaf autumn alkali (or Securinine hydrochloride) 16mg
Citicoline 800mg
All the other join 100ml with 0.9% physiological saline.
Methods for the treatment of is with the embodiment I.
The treatment case
(continued)
Age | The sex occupation | Diagnostic result | The morbidity time limit | Symptom before the treatment | Symptom after the treatment | |
The 1st treats order journey 10 days (with embodiment II prescription) | 20 days the 2nd courses for the treatment of (with embodiment I prescription) | |||||
68 years old | The man cadre | Cerebral infarction basal part right side | So far 14 years | Left limb hemiplegia, the atrophy of muscle severe, myasthenia, elbow joint flexing hang down that wrist, finger grab that Chinese boxing stiff knee, left lower extremity tow, can't squat down, left limb is colder, left hand pastiness, atropurpureus, anoxic | Loosen in the sensation joint, knee joint, ankle-joint loosen, flexing, can do that squatting motion, left arm are raised 200cm, brain feels clear | That the left limb temperature is recovered is normal, leg flexible raise walking, left hand refer to ruddy, need not the crutch walking |
62 years old | The male teacher | The left side cerebral infarction | So far 2 years | Right side limbs knee joint, ankle-joint, hip joint be stiff, lose function fully, right side limb muscle atrophy, elbow joint flexing, the wrist that hangs down, finger are grabbed fist, can't be squatted down | Shank loosens, knee joint is bent knee, the someone holds up alternately to take a step in upper and lower building, right leg strength amount increases, appetite takes a turn for the better | The sensation brain is clear, walking is light, toe crookedly loosens, can be straight, swelling disappearance, arm can lift 40cm, finger can clench fist, can independent upper and lower the 5th buildings, need not crutch |
50 years old | Male worker people | The left side cerebral infarction | So far 3 years | The right side hemiplegia of limb, myasthenia, the elbow joint flexing, finger is clenched fist, and lower limb are stiff, can't squat down, be blind in the left eye, left ear dysacousis, the right side limb temperature is on the low side, it is slow to pronounce, edema of lower extremity, and the knee joint following cyanosis of skin in right side is in obvious Hypoxia and ischemia state. | Right vision returns to 1.0, and auris dextra recovers the sense of hearing, and shank loosens, and is stronger, can do squatting motion, need not to rely on to help can sit down, stand up, can be without the crutch walking. | Right leg strength amount increases, and stands up to sit down easily, squats down easily, and lower extremity swelling and distension disappears, and is stable without the upper and lower six building walkings of crutch energy. |
48 years old | Schoolmarm | Hypertensive cerebral hemorrhage left side Basal ganglia is hemorrhage | So far 3 years | Right side hemiplegia of limb, hand are lifted to the shoulder difficulty, and the right hand is clenched fist and can not be stretched out, and arm puts down and can not stretch, and leg difficulty in walking, right leg take a step to squat down, stand up to need by external force to the layman, right side muscular atrophy, loose, vertical wrist. | The patient feels that brains is clear, and the right side limbs loosen, and it is strong to walk, and the right hand is clenched fist and can be stretched out, and squats down and stands up freely, and easily, right arm can stretch. | Right side brawniness, right arm are can be easily upper to be lifted, and stretches, and can put down the stretching, extension abduction, and it is stronger to walk, upper and lower building freely, hypermnesia, it is normal that gait is recovered substantially. |
50 years old | The woman cadre | Artery sample hardening cerebral thrombotic infarction | So far 2 years | Aphasia, the right side limbs are stiff, and instability of gait is not flexible, and elbow is counted on one's fingers, is bent in the obvious atrophy of right side limbs, unable. | Can say continuously that language reaches 7 words, it is more clear to pronounce, and the strength of walking increases, and elbow joint can stretch and raise, and right hand outward turning can oneself's domination. | Speech can be said 15 more than the word continuously, and the right side myodynamia strengthens, and it is more free and relaxed to walk, and the right hand can be clenched fist |
15 days courses for the treatment of | ||||||
(with embodiment II prescription) | ||||||
10 years old | The man | Myasthenia gravis | The sagging type in upper eyelid: the eyes ptosis, the volume position disappears, and face is stiff, and mimetic muscle is amimia, faces upward face depending on thing. | Patient's transference cure | ||
45 years old | The man | Myasthenia gravis | Cervical muscle and omoplate banding pattern: head turns forward, and it is unable to come back, and salivation is poker-faced | Patient's transference cure | ||
17 years old | The woman | Myasthenia gravis | Upper limbs flesh type: the morbidity upper limbs is sagging, can not lead along by hand, and grip descends, and it is unable to hold thing, the difficulty of writing. | Patient's transference cure | ||
63 years old | The woman | Myasthenia gravis | Oblongata flesh type: asophia is clear, the difficulty of handling up, and xerophagia is not swallowed drinking-water and is choked from nose, heavy nasal sound, the general power of whole body sometimes, mouthful salivation. | Patient's transference cure | ||
37 years old | The woman | Sequelae of infantile paralysis | The lower limb muscles atrophy of patient right side is walked lamely, and sole turns up. | The atrophy muscle recovery approaches normally after treating 2 courses for the treatment of, walks lamely and obviously improves, and sole turns up and recovers normal. |
Claims (2)
1, a kind of composite medicinal injection for the treatment of hemiplegia is characterized in that its composition forms (by working concentration mg/100ml) and is: Cobastab1400-800mg, Cobastab650-100mg, Cobastab125-10mg, danshen injections (crude drug content) 3000-6000mg, ligustrazine phosphat or Ligustrazine Hydrochloride 380-750mg, one leaf autumn of nitric acid alkali or Securinine hydrochloride 8-16mg, citicoline 500-1000mg, all the other are assigned to 100ml with 0.9% physiological saline.
2, parenteral solution according to claim 1 is characterized in that described danshen injections is pure danshen injections or compound injection of red sage root or sodium tashinone II A sulfonate injection.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98122910A CN1067586C (en) | 1998-11-20 | 1998-11-20 | Composite medicinal injection for hemiparalysis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98122910A CN1067586C (en) | 1998-11-20 | 1998-11-20 | Composite medicinal injection for hemiparalysis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1226439A true CN1226439A (en) | 1999-08-25 |
CN1067586C CN1067586C (en) | 2001-06-27 |
Family
ID=5227954
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98122910A Expired - Fee Related CN1067586C (en) | 1998-11-20 | 1998-11-20 | Composite medicinal injection for hemiparalysis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1067586C (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100361672C (en) * | 2004-10-27 | 2008-01-16 | 石家庄欧意药业有限公司 | Red sage root ligustrazine freeze dried injecta and preparation method thereof |
CN108542879A (en) * | 2018-06-19 | 2018-09-18 | 吉林百年汉克制药有限公司 | A kind of injection Citicolini pharmaceutical composition and its preparation method and application |
CN113440537A (en) * | 2021-06-22 | 2021-09-28 | 珠海市脑康康健康科技有限责任公司 | Cerebral apoplexy or apoplexy rehabilitation medicine composition and application thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1122241A (en) * | 1995-09-18 | 1996-05-15 | 牛俊江 | Naomaitong injection for cerebral angiopathy |
CN1174714A (en) * | 1996-12-26 | 1998-03-04 | 刘煌清 | Whole set prescription for rehabilitation of hemiplegia |
CN1190014A (en) * | 1998-02-17 | 1998-08-12 | 刘煌清 | Medicine for hemiplegia |
-
1998
- 1998-11-20 CN CN98122910A patent/CN1067586C/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100361672C (en) * | 2004-10-27 | 2008-01-16 | 石家庄欧意药业有限公司 | Red sage root ligustrazine freeze dried injecta and preparation method thereof |
CN108542879A (en) * | 2018-06-19 | 2018-09-18 | 吉林百年汉克制药有限公司 | A kind of injection Citicolini pharmaceutical composition and its preparation method and application |
CN113440537A (en) * | 2021-06-22 | 2021-09-28 | 珠海市脑康康健康科技有限责任公司 | Cerebral apoplexy or apoplexy rehabilitation medicine composition and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1067586C (en) | 2001-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tweedy et al. | Exercise and sports science Australia (ESSA) position statement on exercise and spinal cord injury | |
Cybulski et al. | Lower extremity functional neuromuscular stimulation in cases of spinal cord injury | |
Nazish et al. | Muslim prayer-a new form of physical activity: A narrative review | |
CN101116761B (en) | Equipment for treating cardiovascular and cerebrovascular diseases | |
Cooper et al. | Electrical treatment of coma via the median nerve | |
US20060095087A1 (en) | Method for treating disease using motion style treatment | |
CN1226439A (en) | Composite medicinal injection for hemiparalysis | |
CN201006128Y (en) | Heart cerebrovascular disease therapeutic equipment | |
Arazpour et al. | Role of gait training in recovery of standing and walking in subjects with spinal cord injury | |
Mehrholz et al. | Jump training is feasible for nearly ambulatory patients after stroke | |
Feldman et al. | Integrating physical therapy with behavior therapy: a case study | |
Xuefei et al. | Study on the effect of rehabilitation therapy based on deep learning on functional recovery of stroke patients with hemiplegia | |
CN2832116Y (en) | Cross device for training walking of hemiparalysis patient | |
Muccio et al. | Electronic orthoses: technology, prototypes, and practices | |
Cavalli et al. | Importance of motor rehabilitation (RIC) in medullary lesions in chronic phase | |
Abdumalikov et al. | Irral Conductivity In Children With Acute Polyneuropathy In The Background Of Treatment | |
Thomas et al. | To evaluate the significance of physiotherapy as a member in stroke rehabilitation team in Punarnava project | |
Fu et al. | Research on the relevant effects of Taijiquan exercise on the changes of lower limb muscle strength in the elderly based on nano biometric IC technology | |
RU2305534C1 (en) | Method of recovery of vertical position for handicapped persons suffering from affection in central nervous system | |
Suresh | Exclusive Modified Constraint-Induced Movement Therapy for Motor Recovery in Left Hemiplegic Patient | |
Zhao et al. | Comprehensive Application of Rehabilitation Technique of Neurological Training | |
Hussain et al. | An Integrated Approach of Yoga and Naturopathy in the Management of Post-Traumatic Stroke-A Case Report | |
Singh et al. | Comparison of functional task training and resistance training to improve grip strength and hand function in elderly male and female population. | |
Barnabas et al. | Development of medical physio device for stroke patients | |
Covalt | Early Exercise for the Convalescent Patient: A modern program of bed exercise prevents deformities due to illness or injury, improves morale, and hastens recovery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |